CS
CELU icon

Credit Suisse’s Celularity CELU Stock Holding History

Credit Suisse’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,788
Closed -$23.1K – 3338
2022
Q4 		$23.1K Sell
1,788
-69
-4% -$1.27K ﹤0.01% 3465
2022
Q3 		$42K Buy
1,857
+56
+3% +$1.7K ﹤0.01% 3544
2022
Q2 		$60K Buy
+1,801
New +$146K ﹤0.01% 3613

Other funds holding CELU

SIC
Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return
CVSC
C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BFO
Biltmore Family Office Charlotte, North Carolina $761M AUM 31.91% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Credit Suisse's CELU Position: Q1 2023 in Review

Credit Suisse sold out of Celularity (CELU) in Q1 2023, closing a stake of 1,788 shares — an estimated $23.1K sold.

Credit Suisse first reported a position in CELU in Q2 2022 and held it in 3 quarters. The position peaked at $60K in Q2 2022. 61 funds tracked by Wall St. Rank hold CELU as of Q1 2023.

  • Credit Suisse reported no remaining Celularity position as of Q1 2023 after selling out during the quarter.
  • Credit Suisse sold 1,788 Celularity shares in Q1 2023, an estimated $23.1K.
  • Credit Suisse first reported a position in Celularity in Q2 2022 and held it in 3 quarters.
  • Credit Suisse's Celularity position peaked at $60K in Q2 2022.
  • 61 funds tracked by Wall St. Rank held Celularity as of Q1 2023.

Based on Credit Suisse's 13F filing for Q1 2023, filed 10 May 2023.